Cisplatin fachinformation ema
Web4 ≥ 500 aber < 1.000 ODER ≥ 50.000 aber < 75.000 Mit den Dosisstufen von Tag 8 behandeln, anschließend Leukozyten-Wachstumsfaktoren ODER WebOverview. Braftovi is a medicine for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Braftovi is used in combination …
Cisplatin fachinformation ema
Did you know?
WebJan 16, 2024 · When used with cisplatin in cervical cancer, Hycamtin is given as an infusion on days 1, 2 and 3 (with cisplatin given on day 1). This is repeated every 21 days for six … WebFachinformation Carboplatin HEXAL® 10 mg/ml 1 1. BEZEICHNUNG DES ARZNEIMITTELS Carboplatin HEXAL® 10 mg/ml Konzentrat zur Herstellung einer Infu-sionslösung 2. QUALITATIVE UND QUANTITATIVE ZU-SAMMENSETZUNG 1 ml Konzentrat zur Herstellung einer In-fusionslösung enthält 10 mg Carboplatin. Jede 5 ml …
WebCisplatin 1mg/ml Injection BP NL/H/0118/004 PL 14510/0017 EBEWE PHARMA UK Cisplatin Neocorp 1 mg/ml – Konzentrat zur Herstellung einer ... European Medicines Agency Keywords: Periodic safety update report single assessment; cisplatin; PSUSA/00000778/202412 Created Date: WebSep 17, 2024 · Overview. Tecentriq is a medicine for treating the following cancers: • urothelial cancer (cancer of the bladder and urinary system); • non-small cell lung cancer …
WebMar 29, 2024 · Tukysa is a cancer medicine that is used to treat breast cancer that is locally advanced or metastatic (has spread to other parts of the body) and when it is HER2-positive. This means the cancer cells produce a protein on their surface, HER2, which stimulates the growth of the cancer. WebÜberempfindlichkeit gegen Cisplatin oder einen der in Abschnitt 6.1 ge-nannten sonstigen Bestandteile. Cisplatin kann bei einigen Patienten allergische Reaktionen hervorrufen. Die Anwendung ist kontraindiziert bei Patienten mit anamnestisch bekannten allergischen Reaktionen auf Cisplatin, anderen platinhaltigen Substanzen
WebMar 30, 2024 · FDA approves durvalumab for extensive-stage small cell lung cancer On March 27, 2024, the Food and Drug Administration approved durvalumab (IMFINZI, AstraZeneca) in combination with etoposide and...
WebPADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used if you: • have received an immunotherapy medicine and chemotherapy that contains platinum, or fitbit charge black screenWebFeb 20, 2024 · Therapeutic indication. Akynzeo is indicated in adults for the: Prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin … can flovent cause runny noseWeb– Cisplatin wird angewendet in Kom-bination mit anderen Chemothera-peutika oder einer Strahlentherapie zur Behandlung des Zervixkarzinoms. – Cisplatin kann als Mono- oder … fitbit charge bargainWebNov 30, 2024 · Cisplatin 1mg/ml Injection BP Active Ingredient: cisplatin Company: Sandoz Limited See contact details ATC code: L01XA01 About Medicine Prescription … fitbit charge broken strapcan flovent inhaler increase blood pressureWebImfinzi is a medicine used to treat lung cancer. It for use in adults with: non-small cell lung cancer (NSCLC) that cannot be removed by surgery but is not getting worse after … can flovent cause loss of voiceWebAug 31, 2024 · Overview Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting. Emend is used in patients aged from 6 months to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer). It is used with chemotherapy that is a moderate or strong trigger of nausea and vomiting. fitbit charge charger replacement